Fig. 1From: Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistanceSummary of demographics for the study population with details of sex, ethnicity, HIV status and risk factors for TBBack to article page